The highly conserved Nanos gene was found to encode a translational repressor necessary for germ-cell development in lower organisms. The mammalian homologue, Nanos2, was recently found to be expressed in the mouse germ cells. Since its disruption caused infertility exclusively in males, we sought to study the significance of this gene in human male reproduction. Here, we describe for the first time the expression pattern of the NANOS2 gene in human tissues and show that it is testis specific. We found that NANOS2 protein is present in prenatal germ cells and at later stages in spermatogenesis. To elucidate the role of NANOS2 in human germ-line development, we screened this gene for mutations in 214 males with isolated sterility and spermatogenic abnormalities. We identified two heterozygous variants, each in a different oligospermic patient, the second allele being the wild-type. The influence of the first variant, a missense mutation H68Q on the sterility phenotype, was not obvious since it was accompanied by a microdeletion within the AZF region of the Y chromosome. The second variant contained a silent mutation, H109H. Although both mutations were situated within the most conserved RNA-binding domain and were absent in 400 fertile males, it is not obvious that they cause male infertility.
Introduction
The Nanos gene encodes a conserved RNA-binding protein, which is implicated in reproduction and is wide-spread in animal world (Mosquera et al., 1993; Kobayashi et al., 1996; Pilon and Weisblat, 1997; Subramaniam and Seydoux, 1999; Mochizuki et al., 2000; Koprunner et al., 2001; Tsuda et al., 2003) . Nanos is best studied in Drosophila where it plays multiple roles in the germ-line development: (i) specification (Hayashi et al., 2004) ; (ii) maintenance of migration of primordial germ cells (PGCs) to primary gonads and inhibition of their mitotic divisions during that stage (Kobayashi et al., 1996; Forbes and Lehmann, 1998) [this inhibition is due to translational repression of cyclin B mRNA by Nanos protein (Asaoka-Taguchi et al., 1999; Kadyrova et al., 2007) ]; (iii) inhibition of apoptosis of germ-line cells in Drosophila embryos [in this case, the Nanos protein represses translation of mRNA encoding an apoptosis stimulator, the so-called head involution defective factor (Sato et al., 2007) ] and finally (iv) maintenance of germ-line stem cells (Wang and Lin, 2004) .
The presence of three paralogue genes Nanos1, Nanos2 and Nanos3 in the mouse and their expression in germ cells reflects multiplication of the Nanos gene during evolution Tsuda et al., 2003) but with preservation of a role in reproduction. Interestingly, the appearance of additional copies of Nanos was followed by functional specification. Namely, the role in migration maintenance of PGCs to primary gonads (Kobayashi et al., 1996; Forbes and Lehmann, 1998) is represented only by Nanos3 protein . Nanos3 expression in the mouse embryo starts in early PGCs is maintained during their migration and stops a few days after they reach primary gonads . Later it was shown however that Nanos3 protein is expressed also in spermatogonia indicating that it might be also involved in maintenance and differentiation of germ cells during spermatogenesis (Tsuda et al., 2006) . Deficiency of Nanos3 protein results in the loss of PGCs during their migration, causing sterility of both male and female mouse individuals . The role of Nanos protein in maintenance of the germ-line stem cells is preserved by Nanos2, but is restricted to male individuals. Interestingly, a second role of Nanos2 is meiosis suppression (Suzuki and Saga, 2008) . Nanos2 expression in the mouse starts in male PGCs just after their determination in primary testes , then decreases shortly before birth, and is maintained in the adult, but only in a limited number of spermatogonia. The loss of Nanos2 expression results in abnormal localization of the male germ cells which are stacked outside seminiferous tubules. Moreover, germ cells were decreased in number and finally lost, resulting in male infertility . It has been recently demonstrated by the same authors that the role of Nanos2 protein in maintenance of the stem cells in neonatal testes is combined with anti-apoptotic activity of this protein in gonocytes of embryonic gonads and also in gonocyte/spermatogonia stages of neonatal testes (Tsuda et al., 2006) . It was recently shown that Nanos2 protein function in the mouse cannot be replaced by Nanos3, whereas the function of Nanos3 can be restored by Nanos2 (Suzuki et al., 2007) . Therefore, it seems that the structural properties of Nanos2 protein are unique and highly specialized in the male germ-cell development.
Knowledge about the human NANOS gene family is scarce. We have recently cloned the NANOS1 homologue (AF275269) and have demonstrated that its expression is limited to male germ cells, being present in spermatogonia, spermatocytes and round spermatids of the adult testes . However, disruption of the mouse homologue, Nanos1, affects neither germ-cell development nor any other developmental process. Therefore, the Nanos1 is not considered a key fertility factor in the mouse . As for the other human homologues, NANOS2 (which is intronless) or NANOS3, neither the expression nor their potential roles have been described.
In the present work, we focused on the role of human NANOS2 in human spermatogenesis given that the mouse homologue of this gene is involved in germ-line development exclusively in males and therefore seems to be an important male fertility factor. First, we sought to define the tissue expression pattern of this gene and localization of NANOS2 in the germ cells of the tubules. Finally, we have performed mutation screening of the NANOS2 gene in men with isolated sterility and a variety of spermatogenic failure phenotypes in order to dissect the role of this gene in germ-cell development of man.
Materials and Methods

Accession codes
All nucleotide and protein numeration refers to human NANOS2 cDNA (BC042883), human NANOS2 protein (AAI17485), human NANOS1 cDNA (NM199461), human NANOS3 cDNA (NM_001098622) and mouse Nanos2 protein (NP_918953).
Northern blotting and PCR amplification of the NANOS2 transcript
To study the expression of the NANOS2 gene in human adult tissues, we PCR-amplified a 248 bp fragment of the 3 0 -untranslated region (3'UTR) (starting at position 692 after the stop codon and ending at position 939) from human testis Marathon cDNA (BD Biosciences Clontech, Palo Alto, MA, USA) using the corresponding complementary 5 0 -TGTTCTTCCCCTTGTTCAGC and antisense 5 0 -AAAGCTAGGCCA TTGCCATT primers. The PCR product was gel purified, checked for identity using two different restriction enzymes and labeled with 32 P dA TP using Random Prime Labeling Kit (Roche Diagnostics, Mannheim, Germany). The probe was hybridized to human multiple tissue northern (MTN) blots (BD Biosciences Clontech). The first human MTN blot contained heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas RNA, whereas the second one contained spleen, thymus, prostate, testis, ovary, small intestine, colon and peripheral blood leukocyte RNA. To normalize for RNA quantity in the slots, a probe encoding b-actin was used. Hybridization was performed at 688C in ExpressHyb solution (BD Biosciences Clontech). Blots were washed and exposed at the presence of autoradiography film at 2808C.
Next, to study prenatal expression, we performed amplification of a 270 bp fragment of NANOS2 gene using N2.2F 5 
Western blotting
We first tested specificity of the rabbit polyclonal antibody which was raised against human NANOS2 protein (from amino acid at position 50 up to the carboxyl terminus) (Abcam, Cambridge, UK). For that purpose, NANOS1, NANOS2 and NANOS3 full-length cDNAs were directionally cloned at BamHI and NotI restriction sites of pEBG vector in fusion with glutathione-S-transferase (GST) and were used to transfect cells of the HEK293FT cell line. The cell lysates were subsequently tested by Western blotting using anti-NANOS2 antibody at 1:50 dilution.
The human testis tissue was obtained from 25 -40-year-old patients who were subject to testis amputation because of injury. Spermatogenesis of these men was normal as tested by classical histological analysis including H&E staining. Protein extracts were obtained in buffer containing 150 mM sodium chloride, 1.0% NP-40, 50 mM Tris pH 8.0 and were analyzed by Western blotting. Detection of NANOS2 protein was performed using anti-NANOS2 antibody previously tested for specificity as described above.
Fluoroimmunohistochemistry
Human adult testis sections were obtained from men with a normal spermatogenic phenotype who underwent testes removal due to prostate cancer, and sections from 24-week prenatal testes were obtained from spontaneous miscarriages. Formalin-fixed, paraffin-embedded tissue sections were treated with 2% sodium borohydride in phosphate-buffered saline (PBS) for 30 min at room temperature after rehydratation, then with 0.1 mol/l glycine for 30 min at room temperature according to Jagla et al. (2000) and Szeszel et al. (2005) and finally with 10 mmol/l sodium citrate for 30 min at 958C for antigen retrieval. Slides were blocked with 10% bovine serum albumin in PBS for 15 min at room temperature followed by overnight incubation at 48C with primary antibody. The slides representing negative controls were co-incubated overnight, but only in PBS. Finally, all the slides were washed two times in PBS and then treated with secondary anti-rabbit antibody conjugated with TRITC (Sigma, Steinheim, Germany) for 1 h at room temperature. After final washes in PBS, slides were dried, mounted and analyzed using a confocal microscope LSM 510 (Zeiss, Germany). We also performed classical histological analysis of testis tissue using H&E staining.
Individuals
The group of 214 infertile males under study manifested pure sterility with azoospermia, very severe oligospermia (,1 Â 10 6 spermatozoa/ml ejaculate), severe oligospermia (,5 Â 10 6 spermatozoa/ml ejaculate) or oligospermia (5-10 Â 10 6 spermatozoa/ml ejaculate) but had no obstruction of their reproductive ducts. The majority of them underwent histological analysis of a testis biopsy. These patients represented a variety of histological phenotypes of seminiferous tubules: sertoli cell-only syndrome, maturation arrest, hypospermatogenesis, mixed phenotypes or testicular atrophy. All the patients had normal 46,XY karyotypes determined on peripheral blood lymphocytes. AZF microdeletion analysis was performed in all the patients by testing for the presence of the commonly used sequence-tagged sites (STSs) (Jaruzelska et al., 2001) . The control group consisted of 400 normal fertile males, all of them having at least two children. All individuals, the patients as well as the fertile men, were Caucasians of Polish origin. DNA samples from males representing other populations were also included but with unknown fertility status: 39 Palestinians, 30 Nigerians, 20 Aborigines, 7 Chinese and 4 Japanese. This study was approved by the Bioethical Committee at the University of Medical Sciences, Poznan, Poland.
Mutation screening
Genomic DNA was extracted from peripheral blood leucocytes using a standard protocol (Sambrook et al., 1989) . The single-strand conformation polymorphism (SSCP) technique was performed as described by Jaruzelska et al. (1999) , to pre-select for the NANOS2 gene variants. For that purpose, two pairs of overlapping primers: N2. UTRs (21 and 63 bp, respectively). Amplification reactions were performed in 10 ml volume containing 0.2 mmol/l each dNTP, 1 mCi a-32 P dATP, 0.4 mmol/l each primer and 50 ng of human genomic DNA and Taq polymerase. Amplification reactions using N2.1F and N2.1R primers contained 40 mmol/l Tricine-KOH, 15 mmol/l KOAc, 3.5 mmol/l Mg(OAc) 2 , 5% dimetyl sulfoxide, 3.75 mg/l bovine serum albumin, 0.005% Nonidet P-40, 0.005% Tween-20, 1.5 mol/l GC-Melt and 1Â Advantage-GC Polymerase Mix (BD Biosciences Clontech), whereas reactions with N2.2F and N2.2R primers contained 50 mmol/l KCl, 10 mmol/l Tris-HCl, pH 8.8, 1.5 mmol/l MgCl 2 , 0.08% Nonidet P40 and 0.25 U Taq polymerase (Fermentas, Vilnus, Lithuania). Thermocycling was performed in a thermal cycler (MJ Research PTC-200, Waltham, MA, USA) in the following conditions: initial denaturation at 948C, 5 min, followed by 30 cycles denaturation at 948C, 30 s, annealing temperature at 608C (N2.1) or 588C (N2.2), 30 s, synthesis at 688C (N2.1) or 728C (N2.2), 45 s, and a final extension at 688C (N2.1) or 728C (N2.2), 7 min. PCR products were denatured, fractionated in native polyacrylamide gels and visualized by autoradiography at 2808C. Detection of the migration variants was confirmed by repeated SSCP. Both strands of the gel-purified (Qiagen Gel Extraction Kit, Hilden, Germany) amplification products were fully sequenced using amplification primers.
Results
Expression of the NANOS2 transcript
To study the tissue expression of the NANOS2 gene, we synthesized a probe representing a fragment of the 3 0 UTR of this gene. We have hybridized this probe with MTN Blots, containing RNA from several human adult tissues. We found only one single band of the expected size, 2.0 kb, which was present exclusively in the slot containing RNA from the testis (Fig. 1A) . We concluded that the NANOS2 gene is testis specific, as is its mouse homologue. We also demonstrated that NANOS2 mRNA is expressed earlier at the prenatal stage corresponding to 7-12 weeks of pregnancy (Fig. 1B) .
Expression of the NANOS2 protein
We demonstrated that anti-NANOS2 antibody used in this study specifically recognizes the NANOS2 protein, and there is no crossreaction either with NANOS1 or with NANOS3 proteins (Fig. 2A , left panels). Using this antibody in Western blot analysis, we detected a single 30 kDa band in human testis protein extracts. However, the molecular mass was significantly higher than the expected 15 kDa ( Fig. 2A, right panel) .
This antibody was further applied to study the NANOS2 protein expression both in a prenatal testis tissue section from a 24-week fetus and in adult testis tissue sections. We found that NANOS2 was present in all germ cells of seminiferous tubules of the 24-week fetus and that the protein was mainly in the cytoplasm (Fig. 2B) . Later on, in adult testis, the expression of the NANOS2 protein was detected in several spermatogenic stages: in cells on the periphery of the tubules which could correspond to spermatogonia, in spermatocytes and finally in round spermatids (Fig. 2C) . The subcellular localization, however, was slightly different in the adult tubules then in prenatal germ cells. Namely, it was more abundant in perinuclear region of the cytoplasm of the germ cells of the adult testis. All together, the expression pattern of NANOS2 protein in the human germ cells is divergent from that of the mouse Nanos2. It is more widely expressed then in the mouse-not only in prenatal germ cells and in a small number of spermatogonia but also in the later spermatogenic stages including spermatocytes and round spermatids. The presence of sertoli cells and later stages representing spermiogenesis in testis tissue was shown by classical H&E staining (Fig. 2D) .
Mutations of the NANOS2 gene
Screening of 214 infertile men for the presence of mutations in the NANOS2 gene revealed two types of sequence variants. The first one c.204 C.A transversion resulted in the missense mutation H68Q located in the conserved functional zinc-finger domain; however, the mutated histidine was not any of histidines that are involved in the formation of the zinc-finger structure. The H68Q mutation was heterozygous, the second allele being the wild-type. This mutation was identified only in one patient with a very severe oligospermia (,1 Â 10 6 spermatozoa/ml ejaculate) (Fig. 3A) . We have verified that it was present neither in the control group of 400 normal fertile males, who had at least two offspring, nor in other worldwide populations. Although we determined that H68Q mutation was inherited from the mother of the proband, we were not able to test the mutation inheritance in other family members because they were not available for the study. Parallel AZF deletion analysis performed in this patient revealed a microdeletion of sY205, sY254, sY624, sY602, sY147 STSs encompassing the DAZ gene. The second variant we have identified, a c.327 T.C transition, was a synonymous mutation within one of the histidine codons, H109H, and as the previous variant was localized within the zinc-finger domain. This variant was heterozygous, the second allele being wild-type (Fig. 3B ) and occurred only in one patient with a very severe oligospermia (,1 Â 10 6 spermatozoa/ml ejaculate) and a histological phenotype of seminiferous tubules corresponding to maturation arrest. Mutation screening of the control group of individuals revealed one additional NANOS2 sequence variant, a c.77 G.A transition, in 3 of 400 fertile men, it was heterozygous and resulted in missense mutation R26Q. However, this mutation was localized upstream from the conserved zinc-finger domain.
Discussion
It has been recently demonstrated that some of the highly conserved proteins that are involved in the translational regulation of specific mRNAs in Drosophila germ cells, like boule, Nanos or Pumilio, are also present in human germ cells (DAZ and BOL, PUMILIO2, NANOS1, respectively) (Reijo et al., 1995; Xu et al., 2001; Spassov and Jurecic, 2002; Jaruzelska et al., 2003; Moore et al., 2003) . It has been further established that those human homologues are able to form complexes, NANOS1-PUMILIO2, PUMILIO2 -DAZl and PUMILIO2-BOL Moore et al., 2003; Urano et al., 2005) , similarly to the corresponding Nanos-Pumilio complex which is crucial for translational regulation in Drosophila (Sonoda and Wharton, 1999) . The structural properties of these factors, as well as their functional relationship, seem to be of crucial importance for human reproduction, as one of them, the male DAZ homologue causes a lack of germ cells when deleted from the Y chromosome AZF region (Reijo et al., 1995) .
To study the role of these conserved proteins in human spermatogenesis and male infertility, we focused on NANOS2 since disruption of the corresponding mouse homologue, Nanos2, has been shown to cause infertility restricted to males . Since no data about the NANOS2 gene has been published, we started by analyzing RNA expression of this gene in the adult human tissues. We have found that it was testes specific (Fig. 1A) and was also present at prenatal developmental stage (Fig. 1B) as previously demonstrated in the mouse . By Western blot on human testis extracts using a specific anti-NANOS2 antibody raised against a human protein, we identified a band of 30 kDa, of a doubled size compared with the expected 15 kDa for NANOS2 protein ( Fig. 2A,  right panel) . To verify this result, we repeated the detection of NANOS2 using two additional commercially available antibodies each of them raised against a human protein and tested for NANOS2 specificity on fusion proteins from transfected HEK293FT, as above. Each time we obtained a single band of a doubled 30 kDa size, in testis protein extracts isolated from different individuals (not shown). However, this significantly lower than expected electrophoretic mobility was not observed in the case of Nanos2 in extracts isolated from prenatal mouse testis (Suzuki et al., 2007) . Given that the size of the human GST fusion protein from transfected somatic cells was as expected, one possibility is that in human testis NANOS2 protein undergoes homodimerization or alternatively, forms a dimer with another unknown protein of a similar size, which resists SDS and temperature denaturation. Such cases were already described by other authors (Tosi et al., 2000) . We cannot exclude, however, a post-translational human testis-specific modification of NANOS2, e.g. glycosylation that is known to significantly slower electrophoretic mobility.
We have further investigated the NANOS2 protein in seminiferous tubules and established that it was expressed in all the germ cells of the 24-week prenatal human testes and its location was mainly cytoplasmic (Fig. 2B) . The expression at that stage of germ-cell development is compatible with it being the Nanos2 mouse homologue, the latter being found in PGCs already committed to the male germ line . Interestingly, in the adult testes, the NANOS2 protein was present in several distinct germ-cell stages, from spermatogonia to round spermatids (Fig. 2C) , similar to the previously reported expression of NANOS1 . This expression pattern in adult men contrasts with the one in the adult mouse, where Nanos2 protein was found to be restricted to a small number of spermatogonia (Tsuda et al., , 2006 . Therefore, this study shows that, contrary to the mouse, NANOS2 in man cannot be considered as a marker of spermatogonia (Tsuda et al., 2006) . Moreover, our results may indicate that the human NANOS2 factor plays several roles in spermatogenesis. To further explore this issue, we screened the NANOS2 gene for mutations in patients manifesting a variety of phenotypes of spermatogenic failure (to date no SNP variant of NANOS2 gene has been present at the NCBI website).
We have identified a missense heterozygous mutation c.204 C.A H68Q in one patient which occurred in the most conserved functional zinc finger RNA-binding domain. The amino acid sequence identity between mouse and human domain is 93.4%. Besides, in both proteins, histidine is present at that position as it is in human NANOS3 (Fig. 3A) . This mutation was absent in our large control group of 400 fertile men originating from the same population and having at least two offspring, nor was it present in DNA samples representing other populations. However, the influence of this sequence variant on infertility was difficult to assess since it was accompanied by a microdeletion within the AZF region on the Y chromosome, encompassing the DAZ gene (not shown). We found no other patient among our cohort carrying the isolated H68Q mutation. The second difficulty was that we had no access to blood samples of remaining family members to be able to find out whether the H68Q mutation segregated with the disease phenotype.
The second variant of the NANOS2 gene identified exclusively among infertile men was the c.327 T.C H109H synonymous mutation, which, as the previous one, was heterozygous and occurred Expression of NANOS2 gene and mutations in sterile men within the conserved RNA-binding domain in one single patient. Although the influence of this base substitution at the level of nucleotide sequence cannot be ruled out, it is not obvious that this variant is causative of infertility.
Taken together, while both mutations have occurred exclusively in infertile patients, in both cases manifesting a very severe oligospermia and the H68Q mutation, as expected was maternally inherited, their involvement in the infertility phenotype is not clear. It was recently demonstrated that the 3 0 UTR of the Nanos2 mRNA is of crucial importance for enhancement of its translation (Tsuda et al., 2006) . Therefore, it would be of interest to screen these patients for mutations in the region encoding the 3 0 UTR of the NANOS2. The SSCP and DNA sequencing results corresponding to H68Q and H109H mutation are presented in A and B, respectively. Migration SSCP variants as well as nucleotide substitution are indicated with arrows. On each panel, the upper chromatogram represents the mutated allele, whereas the lower one corresponds to the wild-type allele. (C) Alignment of the mouse and human NANOS2 proteins. Identical amino acids are marked in grey, RNAbinding zinc finger domain (CCHC)2 is boxed, stars at the bottom indicate cysteine and histidine residues involved in zinc-finger formation. Histidine residues involved in both nucleotide substitutions that were identified in infertile men are indicated in red. Inheritance of the mutation H68Q from the mother is shown in A and the proband is indicated by arrow.
